InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Hansard Adam, Directeur Commercial. Insider active across 2 companies, notably Applied Therapeutics Inc.. Cumulatively, 9 reports have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €315k. History available since 26 May 2021. The latest transaction was filed on 14 March 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hansard Adam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
48,871 股@ US$5.39100.0% 占其流量Common StockSEC:0001096906-24-000493:0
400,000 股0Common StockSEC:0001209191-23-059634:0
965 股@ US$1.971.5% 占其流量Common StockSEC:0001209191-23-057115:0
9,720 股@ US$2.7021.6% 占其流量Common StockSEC:0001209191-23-050890:0
4,495 股@ US$0.913.2% 占其流量Common StockSEC:0001209191-23-003288:0
31,700 股0Common StockSEC:0001209191-22-002968:0
31,700 股0Common StockSEC:0001209191-22-002964:0
31,700 股0Common StockSEC:0001209191-21-070086:0
2,894 股@ US$18.3558.8% 占其流量Common StockSEC:0001209191-21-036685:0
9 条申报中的 9 条
About Hansard Adam
Adam Hansard is the Chief Commercial Officer at Applied Therapeutics Inc. He is responsible for the company's commercial strategy, aiming to maximize growth opportunities and strengthen the company's market position. Adam brings expertise in marketing and business development, contributing to the development of effective strategies to achieve the company's objectives. His experience in the biotechnology sector enables him to navigate a competitive environment and make informed decisions for the company's future.
